TrialUnited European gastroenterology journal2024

Cost-effectiveness and cost-utility of optimized mercaptopurine treatment versus placebo in ulcerative colitis patients: The randomized controlled OPTIC trial.

Mark Löwenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.